Levin Thomas

539 total citations
30 papers, 364 citations indexed

About

Levin Thomas is a scholar working on Infectious Diseases, Oncology and Pharmacology. According to data from OpenAlex, Levin Thomas has authored 30 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Levin Thomas's work include Tuberculosis Research and Epidemiology (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Levin Thomas is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Levin Thomas collaborates with scholars based in India, United States and Canada. Levin Thomas's co-authors include Mahadev Rao, Jill Kolesar, Karthik Udupa, Bobby Reddy, Murali Munisamy, Barbara Leggett, Michael Ward, Joanne Young, J. Searle and Ron Buttenshaw and has published in prestigious journals such as Molecular Cancer, Cancers and Pharmaceutics.

In The Last Decade

Levin Thomas

29 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levin Thomas India 10 153 112 101 55 54 30 364
Mona S. Abdellateif Egypt 12 141 0.9× 105 0.9× 159 1.6× 42 0.8× 42 0.8× 48 418
Congmin Zhang China 10 141 0.9× 71 0.6× 129 1.3× 41 0.7× 29 0.5× 19 348
Nanya Wang China 13 150 1.0× 71 0.6× 148 1.5× 79 1.4× 30 0.6× 29 450
Mahshid Panahi Iran 12 142 0.9× 58 0.5× 119 1.2× 33 0.6× 34 0.6× 48 413
Xingdong Cai China 10 167 1.1× 79 0.7× 74 0.7× 50 0.9× 18 0.3× 23 330
Markéta Trnková Czechia 9 140 0.9× 124 1.1× 127 1.3× 18 0.3× 51 0.9× 18 307
Sayed Mostafa Hosseini Iran 10 142 0.9× 104 0.9× 106 1.0× 41 0.7× 20 0.4× 29 336
Annette Stein Germany 10 187 1.2× 74 0.7× 128 1.3× 29 0.5× 26 0.5× 32 509
Mousumi Majumder India 9 211 1.4× 59 0.5× 95 0.9× 18 0.3× 30 0.6× 17 342

Countries citing papers authored by Levin Thomas

Since Specialization
Citations

This map shows the geographic impact of Levin Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levin Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levin Thomas more than expected).

Fields of papers citing papers by Levin Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levin Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levin Thomas. The network helps show where Levin Thomas may publish in the future.

Co-authorship network of co-authors of Levin Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Levin Thomas. A scholar is included among the top collaborators of Levin Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levin Thomas. Levin Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thomas, Levin, Naveen Dutt, Pankaj Bhardwaj, et al.. (2025). Pharmacogenomic heterogeneity of N-acetyltransferase 2 : a comprehensive analysis of real world data in Indian tuberculosis patients and from literature and database review. Annals of Medicine. 57(1). 2478316–2478316. 2 indexed citations
3.
Thomas, Levin, et al.. (2024). Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis. European Journal of Drug Metabolism and Pharmacokinetics. 49(5). 541–557. 4 indexed citations
4.
Thomas, Levin, et al.. (2024). Influence of N -acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients. Expert Review of Clinical Pharmacology. 17(3). 263–274. 7 indexed citations
5.
Miraj, Sonal Sekhar, et al.. (2024). Isoniazid-induced pancreatitis: A systematic review. Tuberculosis. 148. 102535–102535. 2 indexed citations
6.
Thomas, Levin, et al.. (2024). Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series. European Journal of Clinical Pharmacology. 80(11). 1725–1740. 2 indexed citations
7.
Kolesar, Jill, Levin Thomas, Shirley Lewis, et al.. (2022). Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers. Molecular Cancer. 21(1). 61–61. 15 indexed citations
8.
Thomas, Levin, Sonal Sekhar Miraj, Muralidhar Varma, et al.. (2022). Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models. European Journal of Clinical Pharmacology. 78(10). 1535–1553. 14 indexed citations
9.
Rao, Mahadev, et al.. (2022). Potential Drug-Drug Interactions Between Anti-Cancer Drugs and OtherMedications in Lung Cancer Patients: A Retrospective Study. Current Drug Safety. 18(2). 175–189. 3 indexed citations
10.
Thomas, Levin, Sumit Birangal, Sonal Sekhar Miraj, et al.. (2021). Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data. Therapeutic Advances in Drug Safety. 12. 1561493501–1561493501. 6 indexed citations
11.
Miraj, Sonal Sekhar, Muhammed Rashid, Levin Thomas, et al.. (2021). Effect of Vitamin D Supplementation in Type 2 Diabetes Patients with Tuberculosis: A Systematic Review. Current Diabetes Reviews. 18(4). e020921196096–e020921196096. 1 indexed citations
12.
13.
Thomas, Levin, et al.. (2020). Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies. Archives of Medical Research. 52(3). 261–269. 15 indexed citations
14.
Rao, Mahadev, et al.. (2020). Cannabinoids as an alternative option for conventional analgesics in cancer pain management: A pharmacogenomics perspective. Indian Journal of Palliative Care. 26(1). 129–129. 9 indexed citations
15.
Reddy, Bobby, et al.. (2019). Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology. Journal of Clinical Medicine. 8(3). 373–373. 99 indexed citations
16.
Chandrasekhar, Dilip, et al.. (2016). Incidence and risk factors of hypoglycemia among Type 2 diabetic patients in a South Indian hospital. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 10(2). S22–S25. 8 indexed citations
17.
Thomas, Levin, et al.. (2016). Implications of traditional medicine in the treatment of Hepatitis A in Kerala. Journal of Traditional and Complementary Medicine. 6(3). 316–320. 5 indexed citations
18.
Thomas, Levin, et al.. (2015). Evaluation of demographic and clinical profile of snakebite casualties presented at a tertiary care hospital in Kerala. Clinical Epidemiology and Global Health. 4(3). 140–145. 9 indexed citations
19.
Thomas, Levin, et al.. (2014). A study on prescribing pattern of anti hypertensive medications in a tertiary care hospital in Malabar region. Der pharmacia lettre. 6(4). 132–137. 4 indexed citations
20.
Young, Joanne, Barbara Leggett, Michael Ward, et al.. (1993). Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.. PubMed. 8(3). 671–5. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona S. Abdellateif Breakdown of academic impact, for papers by Congmin Zhang Breakdown of academic impact, for papers by Nanya Wang Breakdown of academic impact, for papers by Mahshid Panahi Breakdown of academic impact, for papers by Xingdong Cai Breakdown of academic impact, for papers by Markéta Trnková Breakdown of academic impact, for papers by Sayed Mostafa Hosseini Breakdown of academic impact, for papers by Annette Stein Breakdown of academic impact, for papers by Mousumi Majumder
Rankless by CCL
2026